ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pradaxa 150 mg, Kapseln - 3 x 60
61385019 Boehringer Ingelheim (Schweiz) GmbH
Pradaxa 150 mg, Kapseln29.05.2012
Original29.05.2012
Dabigatran Etexilate (B01AE07) 
WHO-DDD 
06.03.20.3 x 60
06.03. 
B  
Yes 
IPCI
209.18No
    
10 %256.80
7680613850198Synthetika
7361818 
Composition
dabigatranum etexilatum 150 mg ut dabigatrani etexilati mesilas 172.95 mg, acaciae gummi, acidum tartaricum, hypromellosum, dimeticonum, talcum, hydroxypropylcellulosum, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 171, E 132, aqua purificata, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Dabigatranum Etexilatum150 mg
BAG: Active AgentDose
Dabigatranum Etexilatum150 mg
 
Inactive agents additional_information
(Nigrum)  
Acaciae Gummi  
Tartaric Acid  
Aqua Purificata  
Carrageenanum  
Dimeticone  
E 132 color.
E 171 color.
E 172 color.
Hydroxypropylcellulosum  
Hypromellosum Kapselhülle
Potassium Chloride  
Kalii Hydroxidum  
Lacca Drucktinte
Pro Capsula  
Talcum  
 
Source
Data was imported : 05.05.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home